Accolade, Inc. (ACCD)
Chart Events
Performance Outlook
| Previous Close | 17.97 |
| Open | 17.16 |
| Bid | 18.28 x 900 |
| Ask | 18.46 x 900 |
| Day's Range | 16.59 - 18.91 |
| 52 Week Range | 16.59 - 58.11 |
| Volume | |
| Avg. Volume | 893,393 |
| Market Cap | 1.264B |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Fair Value
Related Research
- Accolade, Inc.Analyst Report: Unitedhealth Group IncBy revenue, UnitedHealth Group is the nation's largest publicly traded managed care company. It operates through two business segments, UnitedHealthcare and Optum. UnitedHealthcare provides healthcare benefits through four membership groups: Employers & Individual, Medicare & Retirement, Community & State, and International. Optum is a health services business that serves payers, care providers, employers, governments, life science companies, and consumers. OptumInsight uses advanced data analytics and technology to help optimize the performance of clients. Optum includes OptumRx, which operates a pharmacy benefit management service (PBM).RatingFair ValueEconomic Moat4 days agoArgus Research
- GlobeNewswire
Accolade to Participate in the 24th Annual Needham Growth Conference
SEATTLE, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 600 employers and millions of members, will participate in 24th Annual Needham Growth Conference, including a presentation on Friday, January 14, 2022 at 12:30 p.m. E.T. A webcast and related presentation materials will be available at ir.accolade.com. About Accolade, Inc. Accolade (Nasdaq: ACCD) provides millions of people and their families with an exceptional healthcare experience
- GlobeNewswire
Accolade Announces Results for Fiscal Third Quarter 2022
Fiscal third quarter 2022 revenue of $83.5 million, a 117% increase compared to fiscal third quarter 2021 revenue of $38.4 million Company introduces preliminary guidance for fiscal year 2023, expecting 25% growth in revenue and a reduction in Adjusted EBITDA lossInitial Accolade One and Accolade Care customers launched on January 1, 2022 SEATTLE, Jan. 10, 2022 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD) today announced financial results for the fiscal third quarter ended November 30, 2021
- GlobeNewswire
Accolade to Announce Fiscal Third Quarter 2022 Financial Results
SEATTLE, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced that it will release fiscal third quarter 2022 financial results on Monday, January 10, 2022, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call Details The conference call can be accessed by dialing 1-833-519-1281 for U.S. parti
